Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Korsana Biosciences, Inc. (KRSA : NSDQ)

• Company Description    Korsana Biosciences Inc. is a biotechnology company discovering and developing novel therapies to reduce the burden of neurodegenerative diseases. Its lead program includes KRSA-028 is a next-generation shuttled antibody targeting amyloid beta for the treatment of Alzheimer's disease. Korsana Biosciences Inc. is based in WALTHAM, Mass. Number of Employees: 1

• Price / Volume Information    Yesterday's Closing Price: $32.54 Daily Weekly Monthly 20 Day Moving Average: 125,013 shares Shares Outstanding: 0.67 (millions) Market Capitalization: $21.77 (millions) Beta: 1.72 52 Week High: $54.21 52 Week Low: $6.46 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 0.74% 0.08% 12 Week 32.86% 25.30% Year To Date 266.14% 223.11%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 245 First Street 18th Floor - CAMBRIDGE,MA 02142 USA ph: 857-327-8778 fax: - ir@cyclerion.com http://www.cyclerion.com

• General Corporate Information    Officers Regina Graul - Chief Executive Officer and President Rhonda Chicko - Chief Financial Officer Errol De Souza - Director Peter Hecht - Director Michael Higgins - Director Peer Information Korsana Biosciences, Inc. (CORR.) Korsana Biosciences, Inc. (RSPI) Korsana Biosciences, Inc. (CGXP) Korsana Biosciences, Inc. (BGEN) Korsana Biosciences, Inc. (GTBP) Korsana Biosciences, Inc. (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 23255M303 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/26 Next Expected EPS Date: 11/11/26 Share - Related Items Shares Outstanding: 0.67 Most Recent Split Date: 9.00 (0.14:1) Beta: 1.72 Market Capitalization: $21.77 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.85 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-2.11 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/11/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 4.28 Price/Cash Flow: - Price / Sales: 10.50 EPS Growth vs. Year Ago Period: -272.73% vs. Previous Quarter: 46.05% Sales Growth vs. Year Ago Period: -43.24% vs. Previous Quarter: 17.14% ROE 09/30/26 - - 06/30/26 - -87.96 03/31/26 - -62.10 ROA 09/30/26 - - 06/30/26 - -74.86 03/31/26 - -55.14 Current Ratio 09/30/26 - - 06/30/26 - 0.82 03/31/26 - 1.80 Quick Ratio 09/30/26 - - 06/30/26 - 0.82 03/31/26 - 1.80 Operating Margin 09/30/26 - - 06/30/26 - - 03/31/26 - - Net Margin 09/30/26 - - 06/30/26 - - 03/31/26 - - Pre-Tax Margin 09/30/26 - - 06/30/26 - -353.00 03/31/26 - -264.73 Book Value 09/30/26 - - 06/30/26 - 7.60 03/31/26 - 10.97 Inventory Turnover 09/30/26 - - 06/30/26 - - 03/31/26 - - Debt-to-Equity 09/30/26 - - 06/30/26 - 0.00 03/31/26 - 0.00 Debt-to-Capital 09/30/26 - - 06/30/26 - 0.00 03/31/26 - 0.00

Powered by Zacks Investment Research ©